162 related articles for article (PubMed ID: 20676143)
1. Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.
Vilgelm AE; Hong SM; Washington MK; Wei J; Chen H; El-Rifai W; Zaika A
Oncogene; 2010 Oct; 29(43):5861-8. PubMed ID: 20676143
[TBL] [Abstract][Full Text] [Related]
2. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
3. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
[TBL] [Abstract][Full Text] [Related]
4. p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells.
Tomkova K; Belkhiri A; El-Rifai W; Zaika AI
Cancer Res; 2004 Sep; 64(18):6390-3. PubMed ID: 15374945
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
[TBL] [Abstract][Full Text] [Related]
6. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
7. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
8. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.
Di Vinci A; Sessa F; Casciano I; Banelli B; Franzi F; Brigati C; Allemanni G; Russo P; Dominioni L; Romani M
Int J Oncol; 2009 Feb; 34(2):449-56. PubMed ID: 19148480
[TBL] [Abstract][Full Text] [Related]
9. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.
Emmrich S; Wang W; John K; Li W; Pützer BM
Mol Cancer; 2009 Aug; 8():61. PubMed ID: 19671150
[TBL] [Abstract][Full Text] [Related]
10. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
Petrenko O; Zaika A; Moll UM
Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
[TBL] [Abstract][Full Text] [Related]
11. ΔNp73 enhances promoter activity of TGF-β induced genes.
Niemantsverdriet M; Nagle P; Chiu RK; Langendijk JA; Kampinga HH; Coppes RP
PLoS One; 2012; 7(12):e50815. PubMed ID: 23236396
[TBL] [Abstract][Full Text] [Related]
12. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
[TBL] [Abstract][Full Text] [Related]
13. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors.
Zaika E; Bhardwaj V; Wei J; Washington MK; Souza R; El-Rifai W; Zaika A
PLoS One; 2013; 8(5):e64306. PubMed ID: 23717592
[TBL] [Abstract][Full Text] [Related]
15. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
[TBL] [Abstract][Full Text] [Related]
16. Induction of the small heat shock protein alphaB-crystallin by genotoxic stress is mediated by p53 and p73.
Evans JR; Bosman JD; Brown-Endres L; Yehiely F; Cryns VL
Breast Cancer Res Treat; 2010 Jul; 122(1):159-68. PubMed ID: 19777343
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines.
Mikulenkova E; Neradil J; Zitterbart K; Sterba J; Veselska R
Tumour Biol; 2015 Sep; 36(10):7483-91. PubMed ID: 25910708
[TBL] [Abstract][Full Text] [Related]
18. Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.
Benosman S; Meng X; Von Grabowiecki Y; Palamiuc L; Hritcu L; Gross I; Mellitzer G; Taya Y; Loeffler JP; Gaiddon C
J Biol Chem; 2011 Dec; 286(50):43013-25. PubMed ID: 22002055
[TBL] [Abstract][Full Text] [Related]
19. Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer.
Logotheti S; Michalopoulos I; Sideridou M; Daskalos A; Kossida S; Spandidos DA; Field JK; Vojtesek B; Liloglou T; Gorgoulis V; Zoumpourlis V
FEBS J; 2010 Jul; 277(14):3014-27. PubMed ID: 20528922
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic mechanisms regulate ΔNP73 promoter function in human tonsil B cells.
Brigati C; Banelli B; Casciano I; Di Vinci A; Matis S; Cutrona G; Forlani A; Allemanni G; Romani M
Mol Immunol; 2011 Jan; 48(4):408-14. PubMed ID: 21129776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
